Abstract | BACKGROUND: In our previous study, we detected decreased expression of phospho-Smad1/5/8 and its upstream signaling molecule, bone morphogenetic protein receptor IB subunit (BMPR-IB), in certain glioblastoma tissues, unlike normal brain tissues. In order to clarify the functional roles and mechanism of BMPR-IB in the development of glioblastoma, we studied the effects of BMPR-IB overexpression on glioblastoma cell lines in vitro and in vivo. METHODS: We selected glioblastoma cell lines U251, U87, SF763, which have different expression of BMPR-IB to be the research subjects. Colony formation analysis and FACS were used to detect the effects of BMPR-IB on the growth and proliferation of glioblastoma cells in vivo. Immunofluresence was used to detect the differentiation changes after BMPR-IB overexpression or knocking-down. Then we used subcutaneous and intracranial tumor models to study the effect of BMPR-IB on the growth and differentiation of glioblastoma cells in vivo. The genetic alterations involved in this process were examined by real-time PCR and western blot analysis.ed. RESULTS AND CONCLUSION: Forced BMPR-IB expression in malignant human glioma cells, which exhibit lower expression of BMPR-IB, induced the phosphorylation and nuclear localization of smad1/5/8 and arrested the cell cycle in G1. Additionally, BMPR-IB overexpression could suppress anchorage-independent growth and promote differentiation of theses glioblastoma cells. Furthermore, overexpression of BMPR-IB inhibited the growth of subcutaneous and intracranial tumor xenografts and prolonged the survival of mice injected intracranially with BMPR-IB-overexpressing glioblastoma cells. Conversely, inhibition of BMPR-IB caused SF763 malignant glioma cells, a line known to exhibit high BMPR-IB expression that does not form tumors when used for xenografts, to show increased growth and regain tumorigenicity in a nude mouse model system, ultimately shortening the survival of these mice. We also observed significant accumulation of p21 and p27kip1 proteins in response to BMPR-IB overexpression. Our study suggests that overexpression of BMPR-IB may arrest and induce the differentiation of glioblastoma cells due to upregulation of p21 and p27kip1 in vitro and that in vivo and decreased expression of BMPR-IB in human glioblastoma cells contributes to glioma tumorigenicity. BMPR-IB could represent a new potential therapeutic target for malignant human gliomas.
|
Authors | Shuang Liu, Feng Yin, Wenhong Fan, Shuwei Wang, Xin-ru Guo, Jian-ning Zhang, Zeng-min Tian, Ming Fan |
Journal | Journal of experimental & clinical cancer research : CR
(J Exp Clin Cancer Res)
Vol. 31
Pg. 52
(May 31 2012)
ISSN: 1756-9966 [Electronic] England |
PMID | 22650359
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CDKN1A protein, human
- Cyclin-Dependent Kinase Inhibitor p21
- Smad Proteins
- Cyclin-Dependent Kinase Inhibitor p27
- BMPR1B protein, human
- Bone Morphogenetic Protein Receptors, Type I
|
Topics |
- Animals
- Bone Morphogenetic Protein Receptors, Type I
(biosynthesis, genetics)
- Brain Neoplasms
(genetics, metabolism, pathology)
- Cell Cycle
(physiology)
- Cell Differentiation
(physiology)
- Cell Line, Tumor
- Cyclin-Dependent Kinase Inhibitor p21
(biosynthesis, genetics, metabolism)
- Cyclin-Dependent Kinase Inhibitor p27
(biosynthesis, genetics, metabolism)
- Female
- Gene Knockdown Techniques
- Glioblastoma
(genetics, metabolism, pathology)
- Humans
- Immunohistochemistry
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Signal Transduction
- Smad Proteins
(biosynthesis, genetics)
- Transfection
- Transplantation, Heterologous
- Up-Regulation
|